factors diabetes, hypertension and obesity. E/e' was significantly lower in patients who performed ≥150 min/week of physical exercise (n=220) compared to <150 min/week (8.6±2.7 vs 10.3±3.5, 95% CI 1.1-2.4, p<0.001). For every increase of 10 min of physical activity per week, E/e' decreased by 4%. 
Risk group
Population Number of CVD events over 10 years Total Under no treatment Had nobody received statins Prevented by current statin coverage Preventable by full statins coverage per guidelines US Moderate 27, 845 (26, 903) 20, 293 (19, 953) 3, 427 (3, 616 (493-738) High 10,600 (9,849-11,580) 5,271 (4,791-5,688) 3,318 (3,210-3,423) Results: Of 71,359 patients admitted with first-time MI during the study period, 65,125 patients survived to begin follow-up on day 15 after admission. The median follow-up time was 3.6 (interquartile range: 1.4-6.5) years and 18,913 (29.0%) patients died during follow-up. During year 1 after MI, MRRs were significantly lower for patients taking any BB dose than for patients taking no BB ( Figure 1A ). Patients taking doses >25-50% TD had the lowest MRR, which was significantly lower than that for patients taking >0-12.5% TD ( Figure 1A ). During year 2 ( Figure 1B ) and year 3 ( Figure 1C ) after MI, doses >12.5% TD were associated with significantly lower MRRs than no BB use and the lowest MRRs were observed for patients taking doses >50-100% TD.
Conclusions: This nationwide study showed that any BB dose during the first year after MI and any BB dose >12.5% TD beyond the first year after MI were associated with significant mortality reduction. During the first year after MI, doses >25-50% TD were associated with maximal mortality reduction, while doses >50% TD were associated with the lowest mortality beyond the first year.
